EUVIMEDEUVIMED entdecken
Crossref

Design and Synthesis of Cryptotanshinone Derivatives with Enhanced Anti-Triple-Negative Breast Cancer Activity via Ferroptosis Induction

Qingyi Shi, Jingwen Guo, Qingyan Sun

Pharmaceutical Fronts · 01.06.2026 · 08 (02) · e142-e154

DOI: 10.1055/a-2867-8073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Fronts, erschienen am 01.06.2026. Verfasst von Qingyi Shi und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer remains the most prevalent malignancy worldwide, with triple-negative breast cancer (TNBC) representing an aggressive subtype lacking effective targeted therapies. Cryptotanshinone (CTS), a bioactive diterpenoid quinone, has demonstrated anti-TNBC activity potentially associated with ferroptosis induction; however, its poor solubility and metabolic instability limit further development. In this study, a series of CTS derivatives was designed by introducing hydroxy acid ester and amino acid ester moieties at the A ring to improve druggability and biological activity. Their antiproliferative activities against TNBC cell lines (4T1 and MDA-MB-231) were evaluated using the CCK-8 assay, and IC50 values were determined for selected compounds. Among 22 synthesized derivatives, 1-(tert-butyl) 2-((1R)-1,6,6-trimethyl-10,11-dioxo-1,2,6,7,8,9,10,11-octahydrophenanthro[1,2-b]furan-9-yl) (2S)-pyrrolidine-1,2-dicarboxylate (AA3-2) exhibited significantly enhanced activity compared with CTS. Mechanistic studies indicated that AA3-2 induced ferroptosis-related cell death, as evidenced by its sensitivity to Ferrostatin-1 and Erastin, along with increased intracellular reactive oxygen species and iron accumulation. These findings suggest that structural modification of CTS can effectively enhance its anti-TNBC activity and support ferroptosis as a potential mechanism, providing a promising lead for further optimization.

Zitieren

APA

Shi, Q., Guo, J., & Sun, Q. (2026). Design and Synthesis of Cryptotanshinone Derivatives with Enhanced Anti-Triple-Negative Breast Cancer Activity via Ferroptosis Induction. Pharmaceutical Fronts, 08(02), e142-e154. https://doi.org/10.1055/a-2867-8073

Vancouver

Shi Q, Guo J, Sun Q. Design and Synthesis of Cryptotanshinone Derivatives with Enhanced Anti-Triple-Negative Breast Cancer Activity via Ferroptosis Induction. Pharmaceutical Fronts. 2026;08(02):e142-e154. doi:10.1055/a-2867-8073

BibTeX
@article{Shi2026,
  author = {Shi, Qingyi and Guo, Jingwen and Sun, Qingyan},
  title = {Design and Synthesis of Cryptotanshinone Derivatives with Enhanced Anti-Triple-Negative Breast Cancer Activity via Ferroptosis Induction},
  journal = {Pharmaceutical Fronts},
  year = {2026},
  volume = {08},
  number = {02},
  pages = {e142--e154},
  doi = {10.1055/a-2867-8073}
}
Kostenlos starten →